With a market cap of $14.8 billion, Viatris Inc. (VTRS) is a global pharmaceutical company formed in 2020 through the merger ...

NEW YORK, NY / ACCESS Newswire / April 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viatris Inc.

Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...

We recently published a list of 12 Best Nasdaq Stocks Under $20 to Buy Now. In this article, we are going to take a look at where Viatris Inc. (NASDAQ:VTRS) stands against other best Nasdaq stocks ...

Today, VTRS has 4 main geographic divisions: Developed Markets, Greater China, JANZ, and Emerging Markets. Lipitor, Celebrex, EpiPen and many other brand names are part of the combined entity ...

Viatris Inc. closed 33.95% short of its 52-week high of $13.55, which the company achieved on November 25th.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We recently published a list of 12 Best Nasdaq Stocks Under $20 to Buy Now. In this article, we are going to take a look at where Viatris Inc. (NASDAQ:VTRS) stands against other best Nasdaq stocks ...

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed ...